| All ACS | STEMI | NSTE-ACS | ||||||
---|---|---|---|---|---|---|---|---|---|
Diabetes/possible diabetes (N = 23,880) | No diabetes (N = 39,570) | p value | Diabetes/possible diabetes (N = 14,650) | No diabetes (N = 25,143) | p value | Diabetes/possible diabetes (N = 9230) | No diabetes (N = 14,427) | p value | |
Age, mean (SD), years | 64.2 (11.9) | 62.1 (12.7) | < 0.001 | 62.9 (12.0) | 61.0 (12.9) | < 0.001 | 66.3 (11.3) | 64.1 (12.2) | < 0.001 |
Women, n (%) | 7159 (30.0) | 8764 (22.2) | < 0.001 | 3904 (26.7) | 4744 (18.9) | < 0.001 | 3255 (35.3) | 4020 (27.9) | < 0.001 |
Vital signs | |||||||||
 SBP levels, mean (SD) | 131.7 (24.3) | 129.1 (22.9) | < 0.001 | 128.4 (24.2) | 126.3 (22.9) | < 0.001 | 136.9 (23.5) | 133.9 (22.1) | < 0.001 |
 DBP levels, mean (SD) | 77.9 (14.5) | 78.0 (14.3) | 0.543 | 77.8 (15.0) | 77.5 (14.6) | 0.629 | 78.4 (13.5) | 78.8 (13.6) | 0.040 |
 Heart rate, mean (SD) | 79.6 (17.2) | 76.1 (15.5) | < 0.001 | 80.0 (17.5) | 76.8 (15.8) | < 0.001 | 79.1 (16.6) | 74.8 (14.8) | < 0.001 |
Risk factors | |||||||||
 Hypertension, n (%) | 17,180 (71.9) | 24,176 (61.1) | < 0.001 | 9961 (68.0) | 14,350 (57.1) | < 0.001 | 7219 (78.2) | 9826 (68.1) | < 0.001 |
 Elevated LDL-Ca, n (%) | 18,024 (83.7) | 30,517 (85.1) | 0.010 | 11,375 (86.5) | 19,760 (86.9) | 0.257 | 6649 (79.3) | 10,757 (82.0) | < 0.001 |
 Low HDL-Cb, n (%) | 10,634 (49.1) | 15,238 (42.4) | < 0.001 | 6293 (47.6) | 9768 (42.8) | < 0.001 | 4341 (51.5) | 5470 (41.6) | < 0.001 |
 Elevated TGc, n (%) | 5194 (23.9) | 5911 (16.4) | < 0.001 | 3094 (23.3) | 3659 (16.0) | < 0.001 | 2100 (24.9) | 2252 (17.1) | < 0.001 |
 Current smoker, n (%) | |||||||||
  Men | 8499 (50.8) | 17,421 (56.6) | < 0.001 | 5848 (54.4) | 12,081 (59.2) | < 0.001 | 2651 (44.4) | 5340 (51.3) | < 0.001 |
  Women | 572 (8.0) | 851 (9.7) | < 0.001 | 371 (9.5) | 547 (11.5) | 0.002 | 201 (6.2) | 304 (7.6) | 0.021 |
History of diseases | |||||||||
 CHD, n (%) | 3197 (13.4) | 3766 (9.5) | < 0.001 | 1186 (8.1) | 1491 (5.9) | < 0.001 | 2011 (21.8) | 2275 (15.8) | < 0.001 |
 Cerebrovascular disease, n (%) | 2911 (12.2) | 3200 (8.1) | < 0.001 | 1587 (10.8) | 1850 (7.4) | < 0.001 | 1324 (14.3) | 1350 (9.4) | < 0.001 |
 Heart failure, n (%) | 706 (3.0) | 553 (1.4) | < 0.001 | 199 (1.4) | 178 (0.7) | < 0.001 | 507 (5.5) | 375 (2.6) | < 0.001 |
 Atrial fibrillation, n (%) | 674 (2.8) | 855 (2.2) | < 0.001 | 253 (1.7) | 328 (1.3) | 0.001 | 421 (4.6) | 527 (3.7) | 0.001 |
 PAD, n (%) | 293 (1.2) | 325 (0.8) | < 0.001 | 102 (0.7) | 145 (0.6) | 0.143 | 191 (2.1) | 180 (1.3) | <0.001 |
 Renal failure, n (%) | 645 (2.7) | 423 (1.1) | < 0.001 | 237 (1.6) | 188 (0.8) | < 0.001 | 408 (4.4) | 235 (1.6) | < 0.001 |
Severe clinical conditions | |||||||||
 Heart failured, n (%) | 2805 (11.9) | 2813 (7.2) | < 0.001 | 1683 (11.6) | 1816 (7.3) | < 0.001 | 1122 (12.3) | 997 (7.0) | < 0.001 |
 Cardiac shocke, n (%) | 874 (3.7) | 1049 (2.7) | < 0.001 | 728 (5.0) | 892 (3.6) | < 0.001 | 146 (1.6) | 157 (1.1) | 0.001 |
 Cardiac arrestf, n (%) | 522 (2.2) | 693 (1.8) | < 0.001 | 427 (2.9) | 605 (2.4) | 0.005 | 95 (1.0) | 88 (0.6) | < 0.001 |
 Killip classg, n (%) |  |  | < 0.001 |  |  | < 0.001 |  |  | < 0.001 |
  II–III | 6700 (28.1) | 9406 (23.8) |  | 3924 (26.9) | 5870 (23.4) |  | 2776 (30.2) | 3536 (24.6) |  |
  IV | 1569 (6.6) | 1725 (4.4) |  | 1147 (7.9) | 1325 (5.3) |  | 422 (4.6) | 400 (2.8) |  |
 Fivefold elevated myocardial injury markerh | 16,800 (72.7) | 26,759 (70.5) | < 0.001 | 11,779 (82.6) | 19,638 (81.0) | < 0.001 | 5021 (56.8) | 7121 (51.9) | < 0.001 |
 GRACE score ≥ 140i, n (%) | 8632 (39.2) | 11,196 (31.2) | < 0.001 | 9074 (65.7) | 16,819 (72) | < 0.001 | 3887 (47.3) | 4644 (37.0) | < 0.001 |
Type of ACS, n (%) |  |  | < 0.001 |  |  |  |  |  |  |
 STEMI | 14,650 (61.4) | 25,143 (63.5) |  | – | – | – | – | – | – |
 NSTE-ACS | 9230 (38.7) | 14,427 (36.5) |  | – | – | – | – | – | – |
Patients with referral, n (%) | 10,148 (42.5) | 18,396 (46.5) | < 0.001 | 7198 (49.2) | 13,347 (53.1) | < 0.001 | 2950 (32.0) | 5049 (35.0) | < 0.001 |